GHSI — Guardion Health Sciences Share News
0.000.00%
Last trade - 00:00- $4.22m
- -$10.60m
- $12.25m
U.S. STOCKS ON THE MOVE-Amphastar Pharma, Snap, Aprea Therapeutics
U.S. STOCKS ON THE MOVE-Disney, Moleculin, Applied DNA
U.S. STOCKS ON THE MOVE-Boeing Co, Seer Inc, Mirum Pharma
Guardion Health: Jumps on new CEO announcement
Brief: Guardion Health Sciences Appoints Bret Scholtes As President And CEO
Brief: Guardion Health Receives Letter From Nasdaq Saying It Has Not Regained Compliance With Price Requirement For Continued Listing
Brief: Guardion Health Sciences Qtrly Rev Rose 57% To $253,000
Brief: Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function And Macular Carotenoid Changes
Brief: Guardion Health Sciences Announces Investigator-Initiated Clinical Trial Of Lumega-Z
Brief: Guardion Provides Update on Strategy, Business Plans and Initiatives
Brief: Guardion Health Sciences Product Licensee Receives Registration Approval In Malaysia For Immune Support Supplement
Brief: Guardion Health Sciences Reports Q2 Loss Per Share Of $0.01
Brief: Guardion Health Sciences Adds Experienced Vice President And Chief Financial Officer To Executive Management Team
Brief: Guardion Subsidiary Vectorvision Receives Approval From Korean Intellectual Property Office For Csv-2000 Trademark
Brief: Guardion Health Sciences Submits Patent Application For Treatment Of Certain Underlying Conditions Related To Eye Disease
Brief: Guardion Health Sciences Names David Evans As Interim President And Interim CEO
Brief: Guardion Health Sciences Reports Q1 2020 Financial Results
U.S. STOCKS ON THE MOVE-Helius Medical, Datadog, Novavax
U.S. STOCKS ON THE MOVE-Datadog, Novavax, Cymabay Therapeutics